Unknown

Dataset Information

0

Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons.


ABSTRACT: Axonal degeneration is a key pathology of neurodegenerative diseases, including hereditary spastic paraplegia (HSP), a disorder characterized by spasticity in the lower limbs. Treatments for HSP and other neurodegenerative diseases are mainly symptomatic. While iPSC-derived neurons are valuable for drug discovery and target identification, these applications require robust differentiation paradigms and rapid phenotypic read-outs ranging between hours and a few days. Using spastic paraplegia type 4 (SPG4, the most frequent HSP subtype) as an exemplar, we here present three rapid phenotypic assays for uncovering neuronal process pathologies in iPSC-derived glutamatergic cortical neurons. Specifically, these assays detected a 51% reduction in neurite outgrowth and a 60% increase in growth cone area already 24?hours after plating; axonal swellings, a hallmark of HSP pathology, was discernible after only 5 days. Remarkably, the identified phenotypes were neuron subtype-specific and not detectable in SPG4-derived GABAergic forebrain neurons. We transferred all three phenotypic assays to a 96-well setup, applied small molecules and found that a liver X receptor (LXR) agonist rescued all three phenotypes in HSP neurons, providing a potential drug target for HSP treatment. We expect this multiparametric and rapid phenotyping approach to accelerate development of therapeutic compounds for HSP and other neurodegenerative diseases.

SUBMITTER: Rehbach K 

PROVIDER: S-EPMC6610147 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons.

Rehbach Kristina K   Kesavan Jaideep J   Hauser Stefan S   Ritzenhofen Swetlana S   Jungverdorben Johannes J   Schüle Rebecca R   Schöls Ludger L   Peitz Michael M   Brüstle Oliver O  

Scientific reports 20190703 1


Axonal degeneration is a key pathology of neurodegenerative diseases, including hereditary spastic paraplegia (HSP), a disorder characterized by spasticity in the lower limbs. Treatments for HSP and other neurodegenerative diseases are mainly symptomatic. While iPSC-derived neurons are valuable for drug discovery and target identification, these applications require robust differentiation paradigms and rapid phenotypic read-outs ranging between hours and a few days. Using spastic paraplegia type  ...[more]

Similar Datasets

| S-EPMC7140514 | biostudies-literature
| S-EPMC2895117 | biostudies-literature
| S-EPMC8422975 | biostudies-literature
| S-EPMC2570635 | biostudies-literature
| S-EPMC3532193 | biostudies-literature
| S-EPMC3990156 | biostudies-literature
| S-EPMC8643509 | biostudies-literature
| S-EPMC3361619 | biostudies-literature
| S-EPMC8578337 | biostudies-literature
| S-EPMC5342682 | biostudies-literature